Erschienen in:
01.01.2010 | Mini Review
Bexarotene: a promising anticancer agent
verfasst von:
Liyan Qu, Xiuwen Tang
Erschienen in:
Cancer Chemotherapy and Pharmacology
|
Ausgabe 2/2010
Einloggen, um Zugang zu erhalten
Abstract
Retinoids are biologically active derivatives of vitamin A, which play essential roles in embryonic or adult cell behavior modulating cell proliferation, differentiation and apoptosis. The biologic effects of retinoids are mediated by two distinct families of intracellular receptors: retinoid acid receptors (RARs)-α, -β and -γ and retinoid X receptors (RXR)-α, -β and -γ. Bexarotene is a selective RXR agonist, which exerts its effects in blocking cell cycle progression, inducing apoptosis and differentiation, preventing multidrug resistance, and inhibiting angiogenesis and metastasis, making it a promising chemopreventive agent against cancer.